Phibro Animal Health Co. (NASDAQ:PAHC) Given Consensus Recommendation of “Strong Sell” by Analysts

Phibro Animal Health Co. (NASDAQ:PAHCGet Free Report) has been assigned an average recommendation of “Strong Sell” from the five ratings firms that are covering the firm, Marketbeat reports. Three investment analysts have rated the stock with a sell recommendation and two have issued a hold recommendation on the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $15.00.

PAHC has been the topic of several recent analyst reports. JPMorgan Chase & Co. assumed coverage on Phibro Animal Health in a report on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price objective on the stock. Bank of America lifted their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a research report on Friday, August 30th.

Get Our Latest Analysis on Phibro Animal Health

Insider Buying and Selling

In other Phibro Animal Health news, Director E Thomas Corcoran bought 5,000 shares of the stock in a transaction on Wednesday, September 4th. The shares were bought at an average price of $20.02 per share, with a total value of $100,100.00. Following the purchase, the director now directly owns 25,000 shares in the company, valued at $500,500. The trade was a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 50.07% of the company’s stock.

Institutional Investors Weigh In On Phibro Animal Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. CWM LLC raised its stake in shares of Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares in the last quarter. nVerses Capital LLC acquired a new position in Phibro Animal Health in the third quarter worth approximately $70,000. Fidelis Capital Partners LLC bought a new position in Phibro Animal Health during the first quarter valued at approximately $46,000. China Universal Asset Management Co. Ltd. lifted its stake in Phibro Animal Health by 63.7% in the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after acquiring an additional 1,522 shares during the last quarter. Finally, Summit Securities Group LLC bought a new stake in Phibro Animal Health in the second quarter worth approximately $83,000. Hedge funds and other institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Trading Up 0.3 %

Phibro Animal Health stock opened at $23.18 on Wednesday. The firm has a market cap of $938.79 million, a price-to-earnings ratio of 386.40, a price-to-earnings-growth ratio of 0.57 and a beta of 0.51. Phibro Animal Health has a 1 year low of $9.40 and a 1 year high of $25.11. The firm’s 50 day moving average price is $22.17 and its two-hundred day moving average price is $19.08. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.64 and a current ratio of 2.94.

Phibro Animal Health (NASDAQ:PAHCGet Free Report) last issued its earnings results on Wednesday, August 28th. The company reported $0.41 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. Phibro Animal Health had a return on equity of 18.08% and a net margin of 0.24%. The business had revenue of $273.16 million for the quarter, compared to analysts’ expectations of $262.44 million. On average, research analysts predict that Phibro Animal Health will post 1.57 EPS for the current fiscal year.

About Phibro Animal Health

(Get Free Report

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

Further Reading

Analyst Recommendations for Phibro Animal Health (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.